## Abstract A series of substituted 3βaminoβ1,2βbenzothiazole dioxides (I) is designed and synthesized.
Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2
β Scribed by Curt D. Haffner; Stephen A. Thomson; Yu Guo; Kimberly Petrov; Andrew Larkin; Pierette Banker; Gregory Schaaf; Scott Dickerson; Jeff Gobel; Dan Gillie; J. Patrick Condreay; Chuck Poole; Tiffany Carpenter; John Ulrich
- Book ID
- 104004962
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 335 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
β¦ Synopsis
a b s t r a c t
We report the synthesis and in vitro activity of a series of novel substituted N-{3-[(1,1-dioxido-1,2benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs. These analogs showed potent inhibitory activity against Kv1.3. Several demonstrated similar potency to the known Kv1.3 inhibitor PAP-1 when tested under the IonWorks patch clamp assay conditions. Two compounds 13i and 13rr were advanced further as potential tool compounds for in vivo validation studies.
π SIMILAR VOLUMES
We report the synthesis and in vitro activity of a series of novel N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs. These analogs showed potent inhibitory activity against Kv1.3. Several compounds, including compound 8b, showed similar potency to the known Kv1.3 inhib
## Abstract magnified image Fourteen novel substituted __N__β[4(5βmethyl/phenylβ1,3,4βoxadiazolβ2βyl)β3,6βdihydropyridinβ1(2__H__)βyl] benzamide/benzene sulfonamides (**11a**, **11b**, **11c**, **11d**, **11e**, **11f**, **11g**, **11h**, **11i**, **11j**, **11k**, **11l**, **11m**, **11n**) were